Systematic review and network meta-analysis of the efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in comparison with other long …
MK Siddiqui, P Shukla, M Jenkins… - Therapeutic …, 2019 - journals.sagepub.com
Background: Dual bronchodilation with a long-acting muscarinic antagonist (LAMA)/long-
acting β2-agonist (LABA) fixed-dose combination (FDC) is an established treatment strategy …
acting β2-agonist (LABA) fixed-dose combination (FDC) is an established treatment strategy …
Systematic review and network meta-analysis of the efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in comparison with other long …
MK Siddiqui, P Shukla, M Jenkins… - Therapeutic …, 2019 - search.ebscohost.com
Background: Dual bronchodilation with a long-acting muscarinic antagonist (LAMA)/long-
acting β< sub> 2-agonist (LABA) fixed-dose combination (FDC) is an established treatment …
acting β< sub> 2-agonist (LABA) fixed-dose combination (FDC) is an established treatment …
Systematic review and network meta-analysis of the efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in comparison with other long …
GF Burton, J Siddiqui, P Shukla, M Jenkins… - … in Respiratory Disease, 2019 - hero.epa.gov
Background: Dual bronchodilation with a long-acting muscarinic antagonist (LAMA)/long-
acting beta (2)-agonist (LABA) fixed-dose combination (FDC) is an established treatment …
acting beta (2)-agonist (LABA) fixed-dose combination (FDC) is an established treatment …
Systematic review and network meta-analysis of the efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in comparison with other long …
MK Siddiqui, P Shukla, M Jenkins… - Therapeutic …, 2019 - europepmc.org
Background Dual bronchodilation with a long-acting muscarinic antagonist (LAMA)/long-
acting β 2-agonist (LABA) fixed-dose combination (FDC) is an established treatment strategy …
acting β 2-agonist (LABA) fixed-dose combination (FDC) is an established treatment strategy …
Systematic review and network meta-analysis of the efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in comparison with other long …
MK Siddiqui, P Shukla, M Jenkins… - Therapeutic …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Dual bronchodilation with a long-acting muscarinic antagonist (LAMA)/long-
acting β 2-agonist (LABA) fixed-dose combination (FDC) is an established treatment strategy …
acting β 2-agonist (LABA) fixed-dose combination (FDC) is an established treatment strategy …
[HTML][HTML] Systematic review and network meta-analysis of the efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in comparison with other …
MK Siddiqui, P Shukla, M Jenkins… - Therapeutic …, 2019 - ncbi.nlm.nih.gov
Background: Dual bronchodilation with a long-acting muscarinic antagonist (LAMA)/long-
acting β 2-agonist (LABA) fixed-dose combination (FDC) is an established treatment strategy …
acting β 2-agonist (LABA) fixed-dose combination (FDC) is an established treatment strategy …